IBDEI0J1 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8564,2)
 ;;=^5002357
 ;;^UTILITY(U,$J,358.3,8565,0)
 ;;=C22.2^^39^401^90
 ;;^UTILITY(U,$J,358.3,8565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8565,1,3,0)
 ;;=3^Hepatoblastoma
 ;;^UTILITY(U,$J,358.3,8565,1,4,0)
 ;;=4^C22.2
 ;;^UTILITY(U,$J,358.3,8565,2)
 ;;=^5000935
 ;;^UTILITY(U,$J,358.3,8566,0)
 ;;=D58.9^^39^401^92
 ;;^UTILITY(U,$J,358.3,8566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8566,1,3,0)
 ;;=3^Hereditary Hemolytic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,8566,1,4,0)
 ;;=4^D58.9
 ;;^UTILITY(U,$J,358.3,8566,2)
 ;;=^5002322
 ;;^UTILITY(U,$J,358.3,8567,0)
 ;;=C81.99^^39^401^93
 ;;^UTILITY(U,$J,358.3,8567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8567,1,3,0)
 ;;=3^Hodgkin Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,8567,1,4,0)
 ;;=4^C81.99
 ;;^UTILITY(U,$J,358.3,8567,2)
 ;;=^5001460
 ;;^UTILITY(U,$J,358.3,8568,0)
 ;;=C81.90^^39^401^94
 ;;^UTILITY(U,$J,358.3,8568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8568,1,3,0)
 ;;=3^Hodgkin Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,8568,1,4,0)
 ;;=4^C81.90
 ;;^UTILITY(U,$J,358.3,8568,2)
 ;;=^5001451
 ;;^UTILITY(U,$J,358.3,8569,0)
 ;;=D89.2^^39^401^95
 ;;^UTILITY(U,$J,358.3,8569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8569,1,3,0)
 ;;=3^Hypergammaglobulenemia,Unspec
 ;;^UTILITY(U,$J,358.3,8569,1,4,0)
 ;;=4^D89.2
 ;;^UTILITY(U,$J,358.3,8569,2)
 ;;=^5002455
 ;;^UTILITY(U,$J,358.3,8570,0)
 ;;=D05.12^^39^401^98
 ;;^UTILITY(U,$J,358.3,8570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8570,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,8570,1,4,0)
 ;;=4^D05.12
 ;;^UTILITY(U,$J,358.3,8570,2)
 ;;=^5001931
 ;;^UTILITY(U,$J,358.3,8571,0)
 ;;=D05.11^^39^401^99
 ;;^UTILITY(U,$J,358.3,8571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8571,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,8571,1,4,0)
 ;;=4^D05.11
 ;;^UTILITY(U,$J,358.3,8571,2)
 ;;=^5001930
 ;;^UTILITY(U,$J,358.3,8572,0)
 ;;=D05.10^^39^401^100
 ;;^UTILITY(U,$J,358.3,8572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8572,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Unspec Breast
 ;;^UTILITY(U,$J,358.3,8572,1,4,0)
 ;;=4^D05.10
 ;;^UTILITY(U,$J,358.3,8572,2)
 ;;=^5001929
 ;;^UTILITY(U,$J,358.3,8573,0)
 ;;=D50.0^^39^401^101
 ;;^UTILITY(U,$J,358.3,8573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8573,1,3,0)
 ;;=3^Iron Deficiency Anemia Secondary to Blood Loss
 ;;^UTILITY(U,$J,358.3,8573,1,4,0)
 ;;=4^D50.0
 ;;^UTILITY(U,$J,358.3,8573,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,8574,0)
 ;;=D50.9^^39^401^102
 ;;^UTILITY(U,$J,358.3,8574,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8574,1,3,0)
 ;;=3^Iron Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,8574,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,8574,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,8575,0)
 ;;=C46.9^^39^401^103
 ;;^UTILITY(U,$J,358.3,8575,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8575,1,3,0)
 ;;=3^Kaposi's Sarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,8575,1,4,0)
 ;;=4^C46.9
 ;;^UTILITY(U,$J,358.3,8575,2)
 ;;=^5001108
 ;;^UTILITY(U,$J,358.3,8576,0)
 ;;=C22.0^^39^401^104
 ;;^UTILITY(U,$J,358.3,8576,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8576,1,3,0)
 ;;=3^Liver Cell Carcinoma
 ;;^UTILITY(U,$J,358.3,8576,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,8576,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,8577,0)
 ;;=D05.02^^39^401^105
 ;;^UTILITY(U,$J,358.3,8577,1,0)
 ;;=^358.31IA^4^2
